These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8913318)

  • 1. Study of chronic lymphocytic leukemia cells by FT-IR spectroscopy and cluster analysis.
    Schultz CP; Liu K; Johnston JB; Mantsch HH
    Leuk Res; 1996 Aug; 20(8):649-55. PubMed ID: 8913318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line.
    Liu KZ; Schultz CP; Johnston JB; Beck FW; Al-Katib AM; Mohammad RM; Mantsch HH
    Leukemia; 1999 Aug; 13(8):1273-80. PubMed ID: 10450757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
    Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
    Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
    Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
    Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine.
    Liu KZ; Schultz CP; Johnston JB; Lee K; Mantsch HH
    Leuk Res; 1997; 21(11-12):1125-33. PubMed ID: 9444947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia.
    Duke VM; Gandini D; Sherrington PD; Lin K; Heelan B; Amlot P; Mehta AB; Hoffbrand AV; Foroni L
    Haematologica; 2003 Nov; 88(11):1259-71. PubMed ID: 14607755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
    Frank DA; Mahajan S; Ritz J
    J Clin Invest; 1997 Dec; 100(12):3140-8. PubMed ID: 9399961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
    Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
    Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
    Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
    Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
    Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large granular lymphocytes from B-chronic lymphocytic leukemia patients inhibit normal B cell proliferation.
    Perri RT; Kay NE
    Am J Hematol; 1989 Jul; 31(3):166-72. PubMed ID: 2500849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B.
    Boyd RS; Adam PJ; Patel S; Loader JA; Berry J; Redpath NT; Poyser HR; Fletcher GC; Burgess NA; Stamps AC; Hudson L; Smith P; Griffiths M; Willis TG; Karran EL; Oscier DG; Catovsky D; Terrett JA; Dyer MJ
    Leukemia; 2003 Aug; 17(8):1605-12. PubMed ID: 12886250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelogenous leukemia in the course of chronic lymphocytic leukemia: evidence for an independent clonal origin.
    Zollino M; Genuardi M; Tanci P; Mango G; Rumi C; Mancini R; Neri G
    Leuk Res; 1991; 15(4):269-73. PubMed ID: 2030609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
    J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.